Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 03, 2026
CF Industries (CF) +18% Rally Reflects Tightening Nitrogen Markets

CF Industries (CF) +18% Rally Reflects Tightening Nitrogen Markets

Key Takeaways

  • CF Industries Holdings shares rose roughly 18% over the trailing 30 days, extending a broad 2026 rally that has lifted the stock to record highs.
  • A tightening global nitrogen supply-demand balance, aggravated by Middle East supply disruptions, has supported higher fertilizer prices and margins.
  • Strong free cash flow, a 20% dividend increase, and an ongoing share-repurchase program have reinforced investor confidence.
  • The $3.7 billion Blue Point One low-carbon ammonia joint venture began construction, adding a longer-term growth catalyst.
  • Quarterly momentum reflects durable nitrogen demand and a structural rise in the incentive pricing needed for new capacity.

CF Industries Holdings (CF) Business Snapshot

CF Industries Holdings, Inc. is a leading global producer and distributor of nitrogen-based products, primarily ammonia, granular urea, urea ammonium nitrate (UAN), and ammonium nitrate, which are used largely as crop fertilizers. The company also manufactures industrial products such as diesel exhaust fluid and nitric acid. Operating one of the world's largest ammonia production complexes in Donaldsonville, Louisiana, CF Industries benefits from low-cost North American natural gas feedstock, making it one of the lowest-cost nitrogen producers globally. Investors follow the stock closely because nitrogen fertilizer demand is tied to global crop economics, while the company's cash generation, shareholder returns, and expanding low-carbon ammonia initiatives set it apart within the agricultural inputs sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

CF Industries Holdings (CF) Recent Price Moves: 30 Days and Quarter

Over the trailing 30 days, CF shares climbed approximately 18%, moving from an adjusted close near $117.70 in early August to a recent close around $139.27, which marked a new all-time closing high. The advance was broad-based, with the stock posting a notable five-session winning streak and trading up more than 12% over that stretch alone.

The quarterly trend was similarly constructive. Over the trailing three months, the stock gained roughly 19%, rising from about $116.92 in early June to current levels. This extended a longer-term uptrend that has delivered a year-to-date total return of roughly 82% and pushed shares well above their 52-week closing low of $76.09 set in December 2025.

Drivers Behind the Latest 30-Day Gain

The recent advance was driven primarily by a tightening nitrogen market. Management reported that global nitrogen prices rose significantly as an already tight supply-demand balance was strained further by supply disruptions tied to the Middle East conflict, with an estimated 4–4.5 million metric tons of urea and about 1 million tons of ammonia lost from global trade. Even as prices normalized, supply has remained constrained into 2027.

Company-specific developments added momentum. In July 2026, CF Industries received the final permits needed to begin construction on Blue Point One, its $3.7 billion low-carbon ammonia joint venture in Louisiana, which targets 1.4 million metric tons of annual capacity. The board also raised the quarterly dividend by 20% to $0.60 per share, while the company continued repurchasing shares under its $2 billion buyback authorization. Strong July UAN and ammonia fill programs, reflecting low channel inventories, signaled firm demand heading into the fall application season.

Quarterly Performance Drivers

Over the past three months, the stock's gains reflected a broader re-rating of the nitrogen sector rather than a single event. Second-quarter 2026 net sales rose to $2.22 billion from $1.89 billion a year earlier on higher selling prices across all segments, while CF Industries operated its available ammonia capacity at nearly 98%. Robust operating cash flow, exceeding $1.37 billion in the first half, funded both shareholder returns and strategic reinvestment.

Management emphasized a structural shift: higher global capital costs have raised the incentive price required to justify new nitrogen capacity, lifting the company's baseline mid-cycle earnings power. This narrative, combined with constrained global supply growth lagging demand, supported the stock's re-rating and its relative outperformance against peers such as Nutrien (NTR) and Mosaic (MOS).

Key Factors to Monitor Going Forward

Several factors could shape CF Industries' trajectory in the months ahead. Investors will watch nitrogen and fertilizer pricing closely, along with global demand from key importers such as India and Brazil, where deferred purchases are expected to recover. The pace of the Blue Point One construction timeline and the Yazoo City complex rebuild, targeted for the first half of 2027, will also be important operational milestones. On the capital-return front, continued buybacks and any further dividend increases may influence sentiment, while macroeconomic variables such as natural gas costs, crop commodity prices, and geopolitical developments in the Middle East remain key swing factors. The company's next earnings report is scheduled for November 2026. From what I see, this is important because structural supply constraints appear durable.

Exploring AI Trading Tools for Stocks Like CF

For traders seeking a systematic approach to stocks like CF Industries, I often turn to Tickeron’s AI tools to review signals and patterns. One resource I find helpful is the Trending AI Robots page, which highlights top-performing bots across strategies and timeframes. It lets me quickly scan automated ideas that align with my own risk parameters without sifting through every available option. This kind of data-driven view complements my fundamental analysis and helps me stay disciplined when markets move quickly.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CF

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CF in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 18, 2026

CF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 33 cases where CF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CF's RSI Indicator exited the oversold zone, 17 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 58 cases where CF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.

Following a +1.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where CF advanced for three days, in 245 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

The Aroon Indicator entered an Uptrend today. In 207 of 274 cases where CF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CF as a result. In 67 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for CF turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 37 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

CF moved below its 50-day moving average on September 21, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CF crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.041) is normal, around the industry mean (2.504). P/E Ratio (8.569) is within average values for comparable stocks, (42.983). Projected Growth (PEG Ratio) (0.498) is also within normal values, averaging (0.867). Dividend Yield (0.018) settles around the average of (0.034) among similar stocks. P/S Ratio (2.667) is also within normal values, averaging (1.476).

The Tickeron Profit vs. Risk Rating rating for this company is 33 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. CF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 9.5B. The market cap for tickers in the group ranges from 611 to 51.87B. CTVA holds the highest valuation in this group at 51.87B. The lowest valued company is BHILQ at 611.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was -9%. For the same Industry, the average monthly price growth was -25%, and the average quarterly price growth was 27%. IPI experienced the highest price growth at 4%, while CTVA experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 210%. For the same stocks of the Industry, the average monthly volume growth was 186% and the average quarterly volume growth was 146%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 35
P/E Growth Rating: 60
Price Growth Rating: 65
SMR Rating: 80
Profit Risk Rating: 79
Seasonality Score: 1 (-100 ... +100)
View a ticker or compare two or three
CF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of nitrogen fertilizer products

Industry ChemicalsAgricultural

Industry
Chemicals Agricultural
Address
2375 Waterview Drive
Phone
+1 847 405-2400
Employees
2900
Web
https://www.cfindustries.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.